5 authorised products containing Velpatasvir, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Epclusa 150 mg/37.5 mg coated granules in sachet EU/1/16/1116/003 |
Sofosbuvir, Velpatasvir | Gilead Sciences Ireland UC | — |
| Epclusa 200 mg/50 mg coated granules in sachet EU/1/16/1116/004 |
Sofosbuvir, Velpatasvir | Gilead Sciences Ireland UC | — |
| Epclusa 400 mg/100 mg film-coated tablets EU/1/16/1116/001 |
Sofosbuvir, Velpatasvir | Gilead Sciences Ireland UC | — |
| Vosevi 200 mg/50 mg/50 mg film-coated tablets EU/1/17/1223/002 |
Sofosbuvir, Velpatasvir, Voxilaprevir | Gilead Sciences Ireland UC | — |
| Vosevi 400 mg/100 mg/100 mg film-coated tablets EU/1/17/1223/001 |
Sofosbuvir, Velpatasvir, Voxilaprevir | Gilead Sciences Ireland UC | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.